Treatment with sorafenib plus camrelizumab after splenectomy for primary splenic angiosarcoma with liver metastasis: A case report and literature review

doi:10.12998/wjcc.v10.i9.2818

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 9

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3632)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-1) series.

Item

Count

PDF

216

WORD

102

HTML

1711

Figures (1-8)

310

Tables (1-1)

325

Sum=2664

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

302

Download

666

Sum=968

Mar 26, 2022 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Mar 26, 2022; 10(9): 2818-2828
Published online Mar 26, 2022. doi: 10.12998/wjcc.v10.i9.2818

Full Size Figure Download Figure

Figure 6 Hematoxylin and eosin staining and immunohistochemistry of the specimen. A: Hematoxylin and eosin staining showed the morphology of the tumor cells; B: Immunohistochemistry (IHC) revealed that the patient was positive for CD31, which was characteristic of tumor cells derived from vascular endothelium; C: The results of IHC revealed that the patient was negative for CD34. Shown at × 100 original magnification.

Citation: Pan D, Li TP, Xiong JH, Wang SB, Chen YX, Li JF, Xiao Q. Treatment with sorafenib plus camrelizumab after splenectomy for primary splenic angiosarcoma with liver metastasis: A case report and literature review. World J Clin Cases 2022; 10(9): 2818-2828
URL: https://www.wjgnet.com/2307-8960/full/v10/i9/2818.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i9.2818